Based on our results, of the five markers compared, TRPS1 seems the most sensitive marker for the mammary origin of CK5-expressing TNBCs (most likely to coincide with basal-like breast carcinomas), and might be best exploited in the metastatic setting. This evidence concerns the gene KRT5 and breast carcinoma.